Copyright Reports & Markets. All rights reserved.

Global Nuclear Receptor ROR Gamma Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Nuclear Receptor ROR Gamma Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Product
      • 1.4.2 BBI-6000
      • 1.4.3 GRC-39815Action
      • 1.4.4 R&D Progress
      • 1.4.5 GSK-2981278
      • 1.4.6 IMU-366
      • 1.4.7 INV-17
      • 1.4.8 Others
    • 1.5 Market by End User
      • 1.5.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by End User
      • 1.5.2 Chronic Obstructive Pulmonary Disease
      • 1.5.3 Asthma
      • 1.5.4 Axial Spondyloarthritis
      • 1.5.5 Breast Cancer
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Nuclear Receptor ROR Gamma Market Size
      • 2.1.1 Global Nuclear Receptor ROR Gamma Revenue 2014-2025
      • 2.1.2 Global Nuclear Receptor ROR Gamma Sales 2014-2025
    • 2.2 Nuclear Receptor ROR Gamma Growth Rate by Regions
      • 2.2.1 Global Nuclear Receptor ROR Gamma Sales by Regions
      • 2.2.2 Global Nuclear Receptor ROR Gamma Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Nuclear Receptor ROR Gamma Sales by Manufacturers
      • 3.1.1 Nuclear Receptor ROR Gamma Sales by Manufacturers
      • 3.1.2 Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers
      • 3.1.3 Global Nuclear Receptor ROR Gamma Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nuclear Receptor ROR Gamma Revenue by Manufacturers
      • 3.2.1 Nuclear Receptor ROR Gamma Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2014-2019)
    • 3.3 Nuclear Receptor ROR Gamma Price by Manufacturers
    • 3.4 Nuclear Receptor ROR Gamma Manufacturing Base Distribution, Product Types
      • 3.4.1 Nuclear Receptor ROR Gamma Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Nuclear Receptor ROR Gamma Product Type
      • 3.4.3 Date of International Manufacturers Enter into Nuclear Receptor ROR Gamma Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Nuclear Receptor ROR Gamma Sales by Product
    • 4.2 Global Nuclear Receptor ROR Gamma Revenue by Product
    • 4.3 Nuclear Receptor ROR Gamma Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Nuclear Receptor ROR Gamma Breakdown Data by End User

    6 North America

    • 6.1 North America Nuclear Receptor ROR Gamma by Countries
      • 6.1.1 North America Nuclear Receptor ROR Gamma Sales by Countries
      • 6.1.2 North America Nuclear Receptor ROR Gamma Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Nuclear Receptor ROR Gamma by Product
    • 6.3 North America Nuclear Receptor ROR Gamma by End User

    7 Europe

    • 7.1 Europe Nuclear Receptor ROR Gamma by Countries
      • 7.1.1 Europe Nuclear Receptor ROR Gamma Sales by Countries
      • 7.1.2 Europe Nuclear Receptor ROR Gamma Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Nuclear Receptor ROR Gamma by Product
    • 7.3 Europe Nuclear Receptor ROR Gamma by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Nuclear Receptor ROR Gamma by Countries
      • 8.1.1 Asia Pacific Nuclear Receptor ROR Gamma Sales by Countries
      • 8.1.2 Asia Pacific Nuclear Receptor ROR Gamma Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Nuclear Receptor ROR Gamma by Product
    • 8.3 Asia Pacific Nuclear Receptor ROR Gamma by End User

    9 Central & South America

    • 9.1 Central & South America Nuclear Receptor ROR Gamma by Countries
      • 9.1.1 Central & South America Nuclear Receptor ROR Gamma Sales by Countries
      • 9.1.2 Central & South America Nuclear Receptor ROR Gamma Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Nuclear Receptor ROR Gamma by Product
    • 9.3 Central & South America Nuclear Receptor ROR Gamma by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Nuclear Receptor ROR Gamma by Countries
      • 10.1.1 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Countries
      • 10.1.2 Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Nuclear Receptor ROR Gamma by Product
    • 10.3 Middle East and Africa Nuclear Receptor ROR Gamma by End User

    11 Company Profiles

    • 11.1 Genfit SA
      • 11.1.1 Genfit SA Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Genfit SA Nuclear Receptor ROR Gamma Products Offered
      • 11.1.5 Genfit SA Recent Development
    • 11.2 GlaxoSmithKline Plc
      • 11.2.1 GlaxoSmithKline Plc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Products Offered
      • 11.2.5 GlaxoSmithKline Plc Recent Development
    • 11.3 Aurigene Discovery Technologies Ltd
      • 11.3.1 Aurigene Discovery Technologies Ltd Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Products Offered
      • 11.3.5 Aurigene Discovery Technologies Ltd Recent Development
    • 11.4 Beijing Hanmi Pharmaceutical Co Ltd
      • 11.4.1 Beijing Hanmi Pharmaceutical Co Ltd Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Products Offered
      • 11.4.5 Beijing Hanmi Pharmaceutical Co Ltd Recent Development
    • 11.5 Biogen Inc
      • 11.5.1 Biogen Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Biogen Inc Nuclear Receptor ROR Gamma Products Offered
      • 11.5.5 Biogen Inc Recent Development
    • 11.6 AbbVie Inc
      • 11.6.1 AbbVie Inc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 AbbVie Inc Nuclear Receptor ROR Gamma Products Offered
      • 11.6.5 AbbVie Inc Recent Development
    • 11.7 Eurofins Advinus
      • 11.7.1 Eurofins Advinus Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Eurofins Advinus Nuclear Receptor ROR Gamma Products Offered
      • 11.7.5 Eurofins Advinus Recent Development
    • 11.8 Brickell Biotech Inc
      • 11.8.1 Brickell Biotech Inc Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Products Offered
      • 11.8.5 Brickell Biotech Inc Recent Development
    • 11.9 Pfizer Inc
      • 11.9.1 Pfizer Inc Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Pfizer Inc Nuclear Receptor ROR Gamma Products Offered
      • 11.9.5 Pfizer Inc Recent Development
    • 11.10 Phenex Pharmaceuticals AG
      • 11.10.1 Phenex Pharmaceuticals AG Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Products Offered
      • 11.10.5 Phenex Pharmaceuticals AG Recent Development
    • 11.11 Reata Pharmaceuticals Inc
    • 11.12 Bristol-Myers Squibb Company
    • 11.13 Celgene Corp
    • 11.14 Eli Lilly
    • 11.15 Glenmark Pharmaceuticals Ltd
    • 11.16 Lead Pharma Holding BV

    12 Future Forecast

    • 12.1 Nuclear Receptor ROR Gamma Market Forecast by Regions
      • 12.1.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Regions 2019-2025
    • 12.2 Nuclear Receptor ROR Gamma Market Forecast by Product
      • 12.2.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Product 2019-2025
      • 12.2.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Product 2019-2025
    • 12.3 Nuclear Receptor ROR Gamma Market Forecast by End User
    • 12.4 North America Nuclear Receptor ROR Gamma Forecast
    • 12.5 Europe Nuclear Receptor ROR Gamma Forecast
    • 12.6 Asia Pacific Nuclear Receptor ROR Gamma Forecast
    • 12.7 Central & South America Nuclear Receptor ROR Gamma Forecast
    • 12.8 Middle East and Africa Nuclear Receptor ROR Gamma Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Nuclear Receptor ROR Gamma Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Nuclear Receptor ROR Gamma market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nuclear Receptor ROR Gamma market based on company, product type, end user and key regions.

      This report studies the global market size of Nuclear Receptor ROR Gamma in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Receptor ROR Gamma in these regions.
      This research report categorizes the global Nuclear Receptor ROR Gamma market by top players/brands, region, type and end user. This report also studies the global Nuclear Receptor ROR Gamma market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Genfit SA
      GlaxoSmithKline Plc
      Aurigene Discovery Technologies Ltd
      Beijing Hanmi Pharmaceutical Co Ltd
      Biogen Inc
      AbbVie Inc
      Eurofins Advinus
      Brickell Biotech Inc
      Pfizer Inc
      Phenex Pharmaceuticals AG
      Reata Pharmaceuticals Inc
      Bristol-Myers Squibb Company
      Celgene Corp
      Eli Lilly
      Glenmark Pharmaceuticals Ltd
      Lead Pharma Holding BV

      Market size by Product
      BBI-6000
      GRC-39815Action
      R&D Progress
      GSK-2981278
      IMU-366
      INV-17
      Others
      Market size by End User
      Chronic Obstructive Pulmonary Disease
      Asthma
      Axial Spondyloarthritis
      Breast Cancer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Nuclear Receptor ROR Gamma market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Nuclear Receptor ROR Gamma market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Nuclear Receptor ROR Gamma companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Nuclear Receptor ROR Gamma submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Nuclear Receptor ROR Gamma are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Receptor ROR Gamma market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now